Status:
COMPLETED
Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 1
Eligibility:
All Genders
6+ years
Brief Summary
This trial is conducted in Europe. The aim of this observational study is to evaluate the glycaemic control in patients with type 1 or 2 diabetes using NovoMix® 30 or Levemir® under normal clinical p...
Eligibility Criteria
Inclusion
- Patients with Type 1 or Type 2 diabetes, including newly diagnosed
- Age: Levemir® above 6 years
- Age: Novomix® above 18 years
Exclusion
- Current treatment with NovoMix® 30 or Levemir®
Key Trial Info
Start Date :
December 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00671008
Start Date
December 1 2007
End Date
September 1 2008
Last Update
January 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sarajevo, Bosnia and Herzegovina